Results 211 to 220 of about 21,426,917 (362)
G protein linked signal transduction pathways in development: Dictyostelium as an experimental system [PDF]
Richard Firtel+3 more
openalex +1 more source
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira+14 more
wiley +1 more source
Ciliary G-Protein Coupled Receptor Signaling in Polycystic Kidney Disease. [PDF]
Buqaileh R, Alshriem LA, AbouAlaiwi W.
europepmc +1 more source
Human Gi protein α‐subunit: deduction of amino acid structure from a cloned cDNA [PDF]
John Didsbury+2 more
openalex +1 more source
Mechanism of the G-protein mimetic nanobody binding to a muscarinic G-protein-coupled receptor
Yinglong Miao, J. McCammon
semanticscholar +1 more source
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian+10 more
wiley +1 more source
G Protein Selectivity in Dopamine Receptors is Determined before GDP Release. [PDF]
Tawfeeq C+5 more
europepmc +1 more source
Co-translational excision of alpha-glucose and alpha-mannose in nascent vesicular stomatitis virus G protein. [PDF]
Paul H. Atkinson, J T Lee
openalex +1 more source
This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga+8 more
wiley +1 more source